A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder

• Main Authors: Kelly C. Allison (Author), Ariana M. Chao (Author), Maija B. Bruzas (Author), Courtney McCuen‐Wurst (Author), Elizabeth Jones (Author), Cooper McAllister (Author), Kathryn Gruber (Author), Robert I. Berkowitz (Author), Thomas A. Wadden (Author), Jena S. Tronieri (Author)
• Format: Book
• Published: Wiley, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Objective To assess the efficacy of liraglutide 3.0 mg, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, for binge eating disorder (BED). Methods Adults with a body mass index (BMI) ≥ 27 kg/m2 enrolled in a pilot, 17‐week double‐blind, randomized controlled trial of liraglutide 3.0 mg/da...